GlucoTrack, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $1.2M
- Price
- $1.15
- % Change (Daily % change from the live per-ticker quote feed.)
- +1.77%
- Volume
- 94.3K
About
GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.
Quick stats
Shares outstanding1.0M
Computed float862.4K
Float / shares84.7%
Cash runway (months)2.7
Key info
SectorHealthcare
IndustryMedical - Devices
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001506983
Websitehttps://www.glucotrack.com
AI Summary
AI-generated1/30
minorbullishpartnership
Lōkahi Therapeutics™ Expands University of Georgia Collaboration Through First International ai² Pipeline™ Project with Universität Paderborn
Lōkahi Therapeutics, a subsidiary of Glucotrack (Nasdaq: GCTK), launched its first international ai² Pipeline project pairing University of Georgia students with Universität Paderborn's garage33 to evaluate international therapeutic assets.
The initiative expands the university network underpinning Lōkahi's fee-for-service model and is positioned to create revenue potential via sponsored projects and asset origination.
No financial terms were disclosed; for a micro-cap like GCTK this is early-stage platform building rather than a near-term revenue event.
Red flags
- no financial terms or committed revenue disclosed
- forward-looking statements cite ongoing need to raise additional capital